10/26/09, (42.88 - 44.25:GILD), $43.43, "SELL-SHORT" Gilead Science (GILD) Stock on Monday, October 26, 2009

Login    About Us    Our Blog    Our Twitter    Contact Us     10/26/09, (42.88 - 44.25:GILD), $43.43, "SELL-SHORT" Gilead Science (GILD) Stock  GILD opened at $44.04 and it is $-0.40, (-0.91%). Today's trading range is $28340. 1y target price is $45.6913.  DOW     -1.05%    -104.22    9867.96           ENGLAND     -0.97%    -50.83    5191.74           JAPAN     Updating    Updating    10362.62  NASDAQ     -0.59%    -12.62    2141.85           GERMANY     -1.71%    -98.09    5642.16           CHINA     +0.06%    +1.72    3109.566  S&P 500     -1.17%    -12.66    1066.94           FRANCE     -1.68%    -63.79    3744.45           INDIA     Updating    Updating    16740.50  CANADA     -1.29%    -147.25    11234.88           ITALY     -1.09%    -174.00    15743.00           RUSSIA     +1.01%    +14.76    1476.06  MEXICO     -0.87%    -265.79    30351.891           SWISS     -1.17%    -74.71    6303.35           TAIWAN     Updating    Updating    7668.40

Stocks Funds SYMBOL:    YouTube Our Blog 10/17/09 StockRing Urgent Advice: Sell stocks on 10/19/09 - expect pull back this week !!!    Option Exp: SAMPLE ! Option Exp: Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!! 1. Dow Jones Index - 30 Stocks on  TODAY :  Buy   77% or 23   Hold   16% or 5   Sell   7% or 2 stocks 2. Best Brands - 200 stocks on  TODAY :  Buy   66% or 132   Hold   13% or 26   Sell   21% or 41 stocks 3. Hot News - 200 stocks on 10/6/2009:  Buy   71% or 141   Hold   -2% or -4   Sell   31% or 62 stocks 4. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341   Hold   21% or 106   Sell   11% or 53 stocks 5. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292   Hold   15% or 61   Sell   12% or 47 stocks 6. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   66% or 395   Hold   26% or 156   Sell   8% or 49 stocks 7. Nasdaq 100 Index - 100 Stocks on 7/21/2009:  Buy   75% or 75   Hold   17% or 17   Sell   8% or 8 stocks 8. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81   Hold   35% or 56   Sell   16% or 27 stocks 9. Nasdaq Biotech - 136 Stocks on 7/24/2009:  Buy   57% or 78   Hold   33% or 45   Sell   10% or 13 stocks 10. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263   Hold   26% or 115   Sell   14% or 62 stocks 11. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109   Hold   6% or 12   Sell   33% or 59 stocks 12. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58   Hold   34% or 34   Sell   8% or 8 stocks 13. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133   Hold   51% or 176   Sell   11% or 37 funds 14. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84   Hold   46% or 73   Sell   2% or 4 funds 15. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19   Hold   50% or 47   Sell   30% or 28 stocks 16. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111   Hold   34% or 70   Sell   13% or 28 stocks     17. World Markets - 72 Indexes on 10/23/2009:  Buy   86% or 60   Hold   4% or 3   Sell   10% or 7 indexes                                              TOTAL RATINGS:   Buy   79% or 2395   Hold   2% or 998   Sell   19% or 535 stocks Video: 10-10-09 - Stock Market Report for S&P 500 stocks 10/26/2009  Monday, October 26, 2009 (Irvine, California) Today StockRing.com Recommendation is to "SELL-SHORT"for Gilead Science (42.88 - 44.25:GILD) Stock. GILD stock opening price was $44.04 per share. Current price of 42.88 - 44.25:GILD Stock is $43.43 per share and it is $-0.40, (-0.91%) today and it was trading in the daily range of $28340 per share. Current Bid Price for (42.88 - 44.25:GILD) stock is $N/A and the Ask Price is $43.44. In the last 52 weeks GILD stock was trading in the range of $39.37 - 53.28. 50-Day Moving Average for (42.88 - 44.25:GILD) stock is $3.110B and 200-Day Moving Average is $45.9049. On average analysts predict that One Year Target Estimated price for (42.88 - 44.25:GILD) stock is $45.6913. Gilead Science (42.88 - 44.25:GILD) Market capitalization is $39.272B. (42.88 - 44.25:GILD) stock average daily volume is 43 shares per day. However, on last trading session of 4:00pm, 2009 GILD stock traded 8,884,847 shares. Also The Short Ratio for (42.88 - 44.25:GILD) stock is 5.977B. On previous trading session GILD Stock closed at $43.83 per share. Last year Gilead Science (42.88 - 44.25:GILD) before taxes (EBITDA) (ttm) earned $43.95 on total revenue of $7.64. Earnings Per Share - EPS (ttm) for GILD stock is 2.379. Also, (42.88 - 44.25:GILD) Stock Price Per Earnings ratio - P/E is 18.42. Thus, (42.88 - 44.25:GILD) Stock Price/Sales (ttm) ratio is 55.29 and Price/Book (mrq) ratio is 6.63. (42.88 - 44.25:GILD) Stock pays a dividend of $ " per share which is a yield of "NasdaqNM"%. So at this time (42.88 - 44.25:GILD) Stock maintains Trailing Annual Dividend Rate at 2.60. StockRing Recommendations for Gilead Science (42.88 - 44.25:GILD) Stock are updated daily here http://www.StockRing.com/sr/StockDetail.asp?StockName=GILD If you would like to receive Buy-Sell-Hold ratings for over 50,000 stocks, mutual funds, and ETFs go to StockRing web site: http://www.StockRing.com. GILD Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max   News    Options!   More Info 10/26/2009 1 Year Stock market price chart for Gilead Science (42.88 - 44.25:GILD) Stock on Monday, October 26, 2009    1 Year Dow Jones Chart 1 Year S&P 500 Chart 1 Year Nasdaq Chart 1 Year Canada Chart 10/26/2009 5 days Stock market price chart for Gilead Science (42.88 - 44.25:GILD) Stock on Monday, October 26, 2009    5 Days Dow Jones Chart 5 Days S&P 500 Chart 5 Days Nasdaq Chart 5 Days Canada Chart GILD Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max   News    Options!   More Info 10/26/2009 Stock market price quote data for Gilead Science (42.88 - 44.25:GILD) Stock on Monday, October 26, 2009 Last Trade: 43.43 Trade Time: 4:00pm Change: -0.40, (-0.91%) Prev Close: 43.83 Open: 44.04 Bid: 43.95 Ask: 0.00 1y Target Est: $45.6913 50-Day Moving Average: 3.110B 200-Day Moving Average: 45.9049 Short Ratio: 5.977B Trailing Annual Dividend Rate: 2.60 Day's Range: 28340 52wk Range: 39.37 - 53.28 Volume: 8,884,847 Avg Vol: 43 Market Cap: 39.272B P/E (ttm): 18.42 EPS (ttm): 2.379 Div & Yield: " ("NasdaqNM"%) Revenue (ttm): 7.64 Earnings before Tax (EBITDA) (ttm): 43.95 Price/Sales (ttm): 55.29 Price/Book (mrq): 6.63 Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!! 1. Dow Jones Index - 30 Stocks on  TODAY :  Buy   77% or 23   Hold   16% or 5   Sell   7% or 2 stocks 2. Best Brands - 200 stocks on  TODAY :  Buy   66% or 132   Hold   13% or 26   Sell   21% or 41 stocks 3. Hot News - 200 stocks on 10/6/2009:  Buy   71% or 141   Hold   -2% or -4   Sell   31% or 62 stocks 4. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341   Hold   21% or 106   Sell   11% or 53 stocks 5. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292   Hold   15% or 61   Sell   12% or 47 stocks 6. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   66% or 395   Hold   26% or 156   Sell   8% or 49 stocks 7. Nasdaq 100 Index - 100 Stocks on 7/21/2009:  Buy   75% or 75   Hold   17% or 17   Sell   8% or 8 stocks 8. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81   Hold   35% or 56   Sell   16% or 27 stocks 9. Nasdaq Biotech - 136 Stocks on 7/24/2009:  Buy   57% or 78   Hold   33% or 45   Sell   10% or 13 stocks 10. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263   Hold   26% or 115   Sell   14% or 62 stocks 11. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109   Hold   6% or 12   Sell   33% or 59 stocks 12. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58   Hold   34% or 34   Sell   8% or 8 stocks 13. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133   Hold   51% or 176   Sell   11% or 37 funds 14. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84   Hold   46% or 73   Sell   2% or 4 funds 15. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19   Hold   50% or 47   Sell   30% or 28 stocks 16. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111   Hold   34% or 70   Sell   13% or 28 stocks     17. World Markets - 72 Indexes on 10/23/2009:  Buy   86% or 60   Hold   4% or 3   Sell   10% or 7 indexes                                              TOTAL RATINGS:   Buy   79% or 2395   Hold   2% or 998   Sell   19% or 535 stocks 10/26/2009 Latest stock market news data for Gilead Science (42.88 - 44.25:GILD) Stock on Monday, October 26, 2009 Registration Deadline Extended for the California Healthcare Policy Forum Trading Markets - 12 minutes ago LA JOLLA, Calif., Oct 26, 2009 (BUSINESS WIRE) -- GILD -- CHI-California Healthcare Institute today announced that due to high demand, the registration for the 2009 California Healthcare Policy ... Bears take a dose of Gilead Sciences-10/26/2009 NASDAQ - 5 hours ago Gilead Sciences is trying to hold a key support level after gapping lower last week, and the bears smell raw meat. optionMONSTER's Depth Charge monitoring system detected the purchase of 7,500 ... ZymoGenetics, Inc. Endures Analyst Downgrade; ZGEN, CELG, GILD Learning Markets - 7 hours ago Oppenheimer gave the Biotechnology industry some bad news as it announced a downgrade on one of its stocks. ZymoGenetics, Inc. (ZGEN) [Chart - News - Analysis] was downgraded from Perform ... Gilead's Aztreonam for Inhalation Solution to be Reviewed by FDA Anti-Infective Drugs Advisory Committee on December 10, 2009 Business Wire - 8 hours ago FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that aztreonam for inhalation solution, an investigational product for the treatment of infections due to ... Market Report -- In Play (GILD) - MSN Money Gilead Sciences (GILD) Announced that Aztreonam for Inhalation to be Reviewed by US FDA - StreetInsider.com RTT News - Ad-Hoc-News - FierceBiotech Gilead Sciences, Inc.'s Aztreonam For Inhalation Solution To Be Reviewed By FDA Anti-Infective Drugs Advisory Committee ODecember10,2009 Reuters Key Development - 8 hours ago Biogen Idec Inc. Gaps Down on Strong Bearish Selling; BIIB, LIFE, GILD Learning Markets - Oct 23, 2009 (Learning Markets News) -- Biogen Idec Inc. (BIIB - Chart - News - Analysis) gapped down more than 4% today as traders moved out of the stock. Gaps occur most frequently when announcements or new ... 'Mad Money Lightning Round': Gilead's Great TheStreet.com - Oct 22, 2009 By Scott Rutt 10/22/09 - 07:23 PM EDT NEW YORK (TheStreet) -- Here's what Jim Cramer had to say about some of the stocks that callers offered up during the "Mad Money Lightning Round" Thursday ... Lightning Round: Gilead Sciences, ADC Telecom, Bank of America and More - CNBC Gilead Sciences Q3 net income increases Trading Markets - Oct 22, 2009 Oct 22, 2009 (Datamonitor via COMTEX) -- GILD -- Gilead Sciences, a US-based biotechnology company, has reported a net income of $673 million, or $0.72 per diluted share, for the third quarter ... Swine flu attracts online scammers, flooding US market with fake pills Daily Finance - Oct 22, 2009 Standing on the threshold of what looks to be a long, cold winter, many people are already preparing to fight the onslaught of the H1N1 virus, also knows as swine flu, avian flu, Spanish flu or ... Pre-Market Round-Up for October 22, 2009 Sumfolio.com - Oct 22, 2009 Hudson City Bancorp, Inc. (HCBK), Gilead Sciences, Inc. (GILD), and CSX Corporation (CSX) are today's featured story stocks to watch as the market appears to be set for a lower open. Hudson City ... Market Report -- In Play (GILD) MSN Money Briefing.com is the leading Internet provider of live market analysis for US Stock, US Bond, and world FX market participants. and more » Gilead 3Q Pft Rises 36% On Sales Growth, Results Beat Views Wall Street Journal Gilead Sciences Inc.'s (GILD) third-quarter profit soared 36% on sales growth in all its product lines as results beat analysts' expectations. ... Gilead Sciences is in Great HealthInside Futures Morgan Joseph Suggests Buying Shares of Gilead Sciences (GILD) on Any WeaknessStreetInsider.com (subscription) Gilead Sciences 3Q profit rises on HIV treatmentsForbes TheStreet.com (subscription) -Seeking Alpha (blog) -Motley Fool all 62 news articles » BEFORE THE BELL:US Stock Futures Down But Off Lows Wall Street Journal Gilead Sciences Inc.'s (GILD) third-quarter profit soared 36% on sales growth in all its product lines as results beat analysts' expectations. ... and more » US EARNINGS WRAP: Yahoo, Sallie Mae Smash Profit Views Wall Street Journal Gilead Sciences Inc.'s (GILD) third-quarter profit soared 36% on sales growth in all its product lines as results beat analysts' expectations. ... and more » 'Mad Money Lightning Round': Gilead's Great TheStreet.com Gilead Sciences (GILD Quote): "Stop worrying, Gilead is a great stock and patience will be rewarded. " ADC Telecommunications (ADCT Quote): "This one is too ... Cramer's Lightning Round - Stop Worrying About Gilead (10/22/09)Seeking Alpha (blog) Lightning Round: Gilead Sciences, ADC Telecom, Bank of America and MoreCNBC all 20 news articles » ZymoGenetics, Inc. Endures Analyst Downgrade; ZGEN, CELG, GILD Learning Markets Everyone is looking for an edge in the stock market, and quite often, traders turn to stock analysts to get that edge. Upgrades and coverage initiations are ... and more » Last Week to Register for the 2010 IR Global Rankings Reuters ... Gilead Sciences (NASDAQ: GILD); Global Bio-chem Technology Group (HKSE: 0809); Global Sources (NASDAQ: GSOL); Global Sweeteners Holdings (HKSE: 03889); ... and more » Weekly Roundup TheStreet.com (subscription) ... (GILD: Nasdaq, $43.83, 2000 shares, 2.96%) INDUSTRY SECTOR - HEALTHCARE: The company beat by 3 cents on better-than-expected revenue, but the stock sold ... and more » Gilead Sciences Reports 3Q 2009 Financial Results Trading Markets (press release) Oct 24, 2009 (Close-Up Media via COMTEX) -- GILD | Quote | Chart | News | PowerRating -- Gilead Sciences, Inc. has announced its results of operations for ... Johnson & Johnson earnings preview The Daily Deal In July, J&J teamed up with Gilead Sciences Inc. (NASDAQ:GILD) to develop a once-daily pill for treating HIV, the virus that causes AIDs. ... Johnson & Johnson To Report Q3 Results: Earnings PreviewTrading Markets (press release) all 909 news articles » 10/26/2009 News from StockRing Blog about Gilead Science (42.88 - 44.25:GILD) Stock on Monday, October 26, 2009    Abele John   Abrams George    Abrams Jonathan   Ackermann Josef   ACUSHNET   A.I.G.   AIG   Albright Madeleine   AMAZON.COM   AMERITRADE   Andelman David   Andreessen Marc   Angwin Julia   Anthony Jim   APAX PARTNERS   ARCH VENTURE PARTNERS   ARONSSON GROUP   Ashworth Paul   AT&T   AVON BOOKS   Bair Sheila   BANK OF AMERICA   BARCLAYS   Barton Rich   Bassett Angela   BEAR STEARNS   Begich Mark   Bell Bryon   Bennett Tony   Berke Barry   Bernanke Ben   BET   BETSEY JOHNSON   Biaggi Mario   Bierut Michael   Biondi Frank   Blankfein Lloyd   Blinder Alan   Bock Jeff   BOEING   Boncompagni Tatiana   Bond Adam   Bond Victoria   Born Brooksley   BOSTON SCIENTIFIC   BP   Brazinski Daniel   Breslin Jimmy   Brody Kenneth   Brown Greg   Burkle Ron   Burow Kristina   Burrough Bryan   Bush George W.   Callan Erin   CALLAWAY GOLF   CARLYLE GROUP    CASCADE INVESTMENT   Cassano Joseph   Dauman Philippe   De Niro Robert   Dickerson Paul   Dillon Harrison   DISNEY   Dodd Christopher   Donaldson William   Douglas Michael   Draghi Mario   DREAMWORKS SKG   DUTTON   Dykstra Lenny   Eisner Michael   ELECTRONIC ARTS   Emanuel Rahm   ENRON   ESL INVESTMENTS   Evans Robert   Falcone Philip   FANNIE MAE   FEDERATED DEPARTMENT   STORES   FINANCO   Flavin Jennifer   Fleckenstein Bill   Foreman George   Frank Barney   Frears Stephen   FREDDIE MAC   Freston Tom   Friedman Stephen   Fuld Dick   Furman Roy   Garavani Valentino   Gates Bill   Geffen David   Geithner Tim   GENERAL MOTORS   Gensler Gary   Gerdeman Fred   Gibson Charles   GLASSDOOR   GLG PARTNERS   GOLDMAN SACHS   Greenspan Alan   Greenspan Glenn   Grey Brad   Griffin Kathy   Griffin Ken   Grove Andy   HALSTON   HARBINGER CAPITAL   PARTNERS   Harrison Gilbert   Harrison Mya   HCR MANORCARE   HEWLETT-PACKARD   HILCO CONSUMER   CAPITAL   Hohman Robert   JEFFRIES & CO.   Jobs Steve   Johnson Magic   Johnson Robert   Jolie Angelina   Jordan Michael   JP MORGAN CHASE   Kaczynski Ted   Karan Donna   Kargman Jill   Karmazin Mel   Kashkari Neel   King Larry   Knowles Beyonce   KohlbergJerry   KopelmanArie   KopelsonAnne   KopelsonArnold   Korff Ira   Korff Kimberlee   Kurzman David   Lagrange Pierre   Lampert Eddie   Lansing Sherry   LEHMAN BROTHERS   LENDINGTREE   Levitt Arthur   Levy Leon   Liddy Ed   LINKEDIN   Little Edward   Loeb Allan   Lois George   LONG-TERM CAPITAL   MANAGEMENT   Lonski John   Lundgren Terry   MACYS   Madoff Bernie   Marcus Bernie   Marriott Bill   Maskin Eric   Mason Richard   MATTHEW WILLIAMSON   MAY DEPARTMENT   STORES   McCombs Red   McKinnon Mark   McLucas William   Meltzer Allan   MERRILL LYNCH   MGM   MICROSOFT   MIDWAY GAMES   Misner Jeff   Mitchell Andrea   Moglia Joe   Molinaro Sam   MOODYS INVESTORS   SERVICE   Moonves Leslie   Morgan Peter   MORGAN STANLEY   Moses Herb   MOTOROLA   Mozilo Angelo   Murdoch Rupert   Murphy Eddie   MYSPACE   Nader Ralph   Nardelli Bob   NATIONAL AMUSEMENTS   NEWS CORP.   Nicholas Pete   Nicklaus Tack   NICKLAUS DESIGN   NIKE   Norquist Grover   NRDC EQUITY PARTNERS   Obama Barack   ODYSSEY PARTNERS   Oman Brady   OPPENHEIMER & CO.   OReilly Bill   OReilly Tim   OVERTURE FILMS   Paese Michael   Palin Sarah   PALM   Pandit Vikram   PARAMOUNT PICTURES   Partnoy Frank   Pataki George   Paulson Henry   Paulson John   Preston Kelly   Purcell Philip   Pyle Jason   RBS GREENWICH CAPITAL   Reardon Roy   Redstone Brent   Redstone Eddie   Redstone Michael   Redstone Paula   Redstone Phyllis   Redstone Shari   Redstone Sumner   RELIANCE   RENAISSANCE TECHNOLOGIES   ROYAL DUTCH SHELL   Rubin Robert   SAC CAPITAL ADVISORS   SALTON   SAPPHIRE ENERGY   Schiff Stephen   Schrager Ian   Schumer Chuck   Schwartz Alan   Scott Lee   Shields Brooke   SHUTTERFLY   SIEMENS   Silverman Ben   Simons James   SIX APART   SOCIALIZR   SOLAZYME   Sorkin Aaron   Sorkin Andrew Ross   Soros George   Spielberg Steven   Spurlock Morgan   Stallone Sylvester   Stanley Stephen   Staubach Roger   Steel Robert   Steinberg Mark   Stern Andy   Stiglitz Joseph   ST. MARTINS PRESS   Stone Oliver   Sullivan Mark T.   Summers Lawrence   SUTTER HILL VENTURES   TACONIC CAPITAL PARTNERS   DESIGN TOMMY HILFIGER   Travolta John   Trump Ivanka   TSM CAPITAL   CENTURY FOX   AFRIKA   TYCO   UBS   UNITED ARTISTS   UNIVERSAL   VALENTINO FASHION   GROUP   VANTAGE   V AUSTRALIA   VENROCK ASSOCIATES   VIA COM   Volcker Paul   VONAGE   WACHOVIA   Wagner Paula   Wales Jimmy   Wallison Peter   WAL-MART   WarinJoseph   WARNER BROTHERS   WASHINGTON MUTUAL   Waters Maxine   Waxman Henry   Weinstein Bob   Weinstein Harvey   WEINSTEIN CO.   Weiser Stanley   Welch Jack   Welling Beau   Whitacre Ed   White Kevin   Whitehead John   Williams Brian   Wilson Victoria   WMS INDUSTRIES   Wolfson Jonathan    Copyright © 2009 StockRing.com. All rights reserved. Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.

Buy from S&P 500:
Akamai - AKAM
Amazon.com - AMZN
Big Lots - BIG


Sell from S&P 500:
Alcoa - AA
Autodesk - ADSK
Aflac - AFL


Buy from S&P 400 MidCap:
Carmax - KMX
99c Stores - NDN
Netflix - NFLX


Sell from S&P 400 MidCap:
Timken - TKR
Trinity - TRN
Aflac - AFL


Buy from S&P 600 SmallCap:
Coinstar - CSTR
Holly - HOC
Maximus - MMS


Sell from S&P 600 SmallCap:
Barnes - B
Cascade - CAE
Brightpoint - CELL


Buy from Nasdaq 100:
Baidu.com - BIDU
Verisign - VRSN
Yahoo - YHOO


Sell from Nasdaq 100:
Adobe - ADBE
Amgen - AMGN
Costco - COST


Buy from Nasdaq Telecom:
Adtran - ADTN
CalAmp - CAMP
KongZhong - KONG


Sell from Nasdaq Telecom:
iBasis - IBAS
Interphase - INPH
RCN Corp - RCNI


Buy from Nasdaq Biotech:
Eurand - EURX
Illumina - ILMN
Trimeris - TRMS


Sell from Nasdaq Biotech:
Antigenics - AGEN
Celera - CRA
Incyte - INCY


Buy from Nasdaq Computer:
eLoyalty - ELOY
LogicVision - LGVN
Macrovision - MVSN


Sell from Nasdaq Computer:
Amtech - ASYS
Bsquare - BSQR
Corel - CREL


Buy from Nasdaq Finance:
Elbit - EMITF
Chardan - CACA
Tree.com - TREE


Sell from Nasdaq Finance:
BancFirst - BANF
FirstMerit - FMER
Advanta - ADVNA